Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients
Clinical trial NCT01433562 · COMPLETED
Trial details
- NCT number
- NCT01433562
- Sponsor
- Dexa Medica Group
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.